Arthur C. Butcher - May 2, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP& Grp Pres, MedSurg & APAC
Signature: /s/ Susan Thompson, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: May 2, 2023
Transactions value $: -$49,303
Form type: 4
Date filed: 5/3/2023, 04:56 PM
Previous filing: Mar 24, 2023
Next filing: Jun 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+2.1K	+9.14%	$0.00	25.1K	May 2, 2023	Direct	F1
transaction	BSX	Common Stock	Tax liability	-$49.3K	-932	-3.72%	$52.90	24.2K	May 2, 2023	Direct
holding	BSX	Common Stock						2.55K	May 2, 2023	By 401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-2.1K	-24.99%	$0.00	6.31K	May 2, 2023	Common Stock	2.1K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.